ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart …

…, P Ponikowski, PA Poole-Wilson… - European heart …, 2008 - academic.oup.com
ESC Guidelines 2389 disclosure forms are kept on file at the European Heart House,
headquarters of the ESC. Any changes in conflict of interest that arise during the writing period …

[PDF][PDF] The epidemiology of heart failure

…, DA Wood, JW Deckers, PA Poole-Wilson… - European heart …, 1997 - researchgate.net
Methods The Medline Literature Database from January 1966 to June 1995 was searched
using the medical subject headings heart failure (congestive), cardiomyopathy (congestive), …

Stress (Takotsubo) cardiomyopathy—a novel pathophysiological hypothesis to explain catecholamine-induced acute myocardial stunning

…, PSC Rees, S Prasad, PA Poole-Wilson… - Nature clinical practice …, 2008 - nature.com
Stress cardiomyopathy, also referred to as Takotsubo cardiomyopathy, is an increasingly
recognized clinical syndrome characterized by acute reversible apical ventricular dysfunction. …

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial—the Losartan Heart Failure Survival Study ELITE II

B Pitt, PA Poole-Wilson, R Segal, FA Martinez… - The Lancet, 2000 - thelancet.com
… Bertram Pitt, Philip Poole-Wilson, and Robert Segal designed the study and were the primary
investigators; other Steering Committee members (Marvin Konstam, Felipe Martinez, John …

Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET) …

PA Poole-Wilson, K Swedberg, JGF Cleland… - The Lancet, 2003 - thelancet.com
Background β blockers reduce mortality in patients who have chronic heart failure, systolic
dysfunction, and are on background treatment with diuretics and angiotensin-converting …

[HTML][HTML] Ferric carboxymaltose in patients with heart failure and iron deficiency

…, SJ Pocock, PA Poole-Wilson… - … England Journal of …, 2009 - Mass Medical Soc
Background Iron deficiency may impair aerobic performance. This study aimed to determine
whether treatment with intravenous iron (ferric carboxymaltose) would improve symptoms in …

Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS)

…, SG Thompson, PA Poole-Wilson - European heart …, 2005 - academic.oup.com
Aims Large randomized trials have shown that beta-blockers reduce mortality and hospital
admissions in patients with heart failure. The effects of beta-blockers in elderly patients with a …

The Seattle Heart Failure Model: prediction of survival in heart failure

…, P Burton, MD Sullivan, B Pitt, PA Poole-Wilson… - Circulation, 2006 - Am Heart Assoc
Background— Heart failure has an annual mortality rate ranging from 5% to 75%. The purpose
of the study was to develop and validate a multivariate risk model to predict 1-, 2-, and 3-…

Universal definition of myocardial infarction: Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the joint ESC/ACCF/AHA/WHF task force for the …

…, ML Simoons, PA Poole-Wilson… - European Heart …, 2007 - academic.oup.com
Myocardial infarction is a major cause of death and disability worldwide. Coronary atherosclerosis
is a chronic disease with stable and unstable periods. During unstable periods with …

Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure

M Packer, PA Poole-Wilson, PW Armstrong… - Circulation, 1999 - Am Heart Assoc
Background—Angiotensin-converting enzyme (ACE) inhibitors are generally prescribed by
physicians in doses lower than the large doses that have been shown to reduce morbidity …